Indian benchmark equity indices traded in a narrow range and managed to close in the green. Nifty broke its...
Business
Commodity Roundup: UBS moderately constructive on oil, U.S. natural gas
chengwaidefeng/iStock via Getty Images UBS holds a moderately constructive outlook for crude oil and U.S....
Romanian pro-European parties agree to quickly form broad coalition government By Reuters
BUCHAREST (Reuters) - Romania's pro-European parties reached a firm commitment late on Monday to form a...
Apple’s next ultra smartwatch will be able to send texts via satellite
The technology would extend one of Apple’s biggest efforts under Chief Executive Officer Tim Cook: bolstering...
‘Waste, fraud and abuse’ are words that will ring through Minnesota Capitol in 2025
Three words — waste, fraud and abuse — are burrowing deep into the Capitol lexicon ahead of a 2025 legislative...
Altoona McDonald’s visited by Luigi Mangione is flooded with negative reviews after his arrest
Person of interest flagged in CEO killing Person in McDonald's tipped police about person of interest in CEO...
India against China-led investment facilitation proposal at WTO: Official
India is against the move led by countries such as China to push a proposal on investment facilitation at the...
Mumbai Special Court Allows Monetisation Of Mehul Choksi’s Rs 2,566 Crore Property
The CBI registered two more FIRs subsequently. Most of the accused are common to these FIRs. Non-bailable...
Omnicom to acquire Interpublic in $13.3 billion deal, creating largest ad agency
Omnicom Group Inc. has agreed to buy Interpublic Group in a deal that will create the world’s largest...
Oracle misses quarterly results estimates on stiff cloud competition
(Reuters) -Oracle (ORCL) missed Wall Street expectations for second-quarter revenue and adjusted profit on...
Brookfield India REIT’s Rs 3,500 crore institutional placement opens at floor price of Rs 287.55/unit
Brookfield India Real Estate Trust's board on Monday approved raising of funds by institutional placement of...
SELLAS reports positive survival data from mid-stage trial of its leukemia treatment
SELLAS reports positive survival data from mid-stage trial of its leukemia treatment Source link